Mohammad F. Almadani

Mr. Mohammad F. Almadani


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Micro
Verified
Journal Article
Open access
PDF file
IAIsmat F. Almadani
Ismat F. Almadani
MAMohammad F. Almadani
Mohammad F. Almadani
NANour AlSawaftah
Nour AlSawaftah
WAWaad Hussein Abuwatfa
Waad Hussein Abuwatfa
GHGhaleb Adnan Husseini
Ghaleb Adnan Husseini
The non-specific and minimally selective nature of traditional drug administration methods, along with various other limitations, makes the use of drug delivery systems more favorable. Light-responsive, or light-triggered, drug delivery systems provide more controlled and less invasive treatment approaches, addressing the shortcomings of traditional methods. In this paper, we reviewed studies utilizing light-triggered nanoparticles (NPs) for treating cancer and various other diseases, focusing on photodynamic therapy (PDT) and photothermal therapy (PTT) in both in vivo and in vitro applications. Most of the reviewed studies employed synergistic approaches that combined PDT or PTT with other therapeutic methods to leverage the strengths of both techniques and enhance treatment efficiency or to overcome the individual limitations of each method, which is discussed extensively in this paper.